P-Anisic Acid

P-Anisic Acid

SCHEMBL2130101

COc1ccc(C(=O)O)cc1.[KH]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.95
CA2 P00918 5/20 0.95
CES2 O00748 2/20 0.67
CES1 P23141 2/20 0.67
NPC1 O15118 1/20 0.67
POLB P06746 1/20 0.67
RAB9A P51151 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
KDM4E B2RXH2 1/20 0.64
XDH P47989 1/20 0.62
RXRA P19793 1/20 0.62
PARP1 P09874 1/20 0.61
PARP10 Q53GL7 1/20 0.61
PARP2 Q9UGN5 1/20 0.61
PARP4 Q9UKK3 1/20 0.61
CHEK1 O14757 1/20 0.61
ALDH1A1 P00352 1/20 0.58
PLA2G4B P0C869 1/20 0.57
PLK1 P53350 1/20 0.57
KMT2A Q03164 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
P-Anisic Acid SCHEMBL28313273 1.00 CA1 (0.95) CA1CA2CES2CES1NPC1
P-Anisic Acid SCHEMBL1157044 0.98 CA1 (1.00) CA1CA2CES2CES1NPC1
P-Anisic Acid SCHEMBL43335 0.98 CA1 (1.00) CA1CA2CES2CES1NPC1
P-Anisic Acid SCHEMBL1043957 0.95 CA1 (0.95) CA1CA2CES2CES1NPC1
P-Anisic Acid SCHEMBL29790432 0.95 CA1 (0.95) CA1CA2CES2CES1NPC1
P-Anisic Acid SCHEMBL15548197 0.95 CA1 (0.95) CA1CA2CES2CES1NPC1
P-Anisic Acid SCHEMBL17891327 0.95 CA1 (0.95) CA1CA2CES2CES1NPC1
P-Anisic Acid SCHEMBL15347432 0.95 CA1 (0.95) CA1CA2CES2CES1NPC1
P-Anisic Acid SCHEMBL414716 0.95 CA1 (0.95) CA1CA2CES2CES1NPC1
P-Anisic Acid SCHEMBL846287 0.95 CA1 (0.95) CA1CA2CES2CES1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110156733-A A kind of tyrosinase inhibitor and its application 润和生物医药科技(汕头)有限公司 2019-08-23 CN claimed
CN-112467110-A Organic battery electrode and preparation method thereof 黄涛 2021-03-09 CN disclosed
US-9596849-B2 Composition containing sorbitan monocaprylate and alcohol CLARIANT INTERNATIONAL LTD. (CH) 2017-03-21 US disclosed
CN-104396951-A Composition containing sorbitan monocaprylate and antimicrobial substances CLARIANT INT LTD 2015-03-11 CN disclosed
US-8969390-B2 Composition containing sorbitan monocaprylate and antimicrobial substances CLARIANT FINANCE (BVI) LIMITED (VG) 2015-03-03 US disclosed
CN-102480944-B Compositions containing sorbitan monocaprylate and antimicrobial actives CLARIANT INT LTD 2014-12-10 CN disclosed
CN-102438451-B Composition containing sorbitan monocaprylate and alcohol CLARIANT FINANCE BVI LTD 2014-03-12 CN disclosed
CN-102480944-A Compositions containing sorbitan monocaprylate and antimicrobial actives CLARIANT INT LTD 2012-05-30 CN disclosed
CN-102438451-A Composition containing sorbitan monocaprylate and alcohol CLARIANT FINANCE BVI LTD 2012-05-02 CN disclosed
US-20120100085-A1 COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND ALCOHOL CLARIANT FINANCE (BVI) LIMITED (VG) 2012-04-26 US disclosed
US-20120101135-A1 COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND ANTIMICROBIAL SUBSTANCES CLARIANT FINANCE (BVI) LIMITED (VG) 2012-04-26 US disclosed
CN-101070300-B Linonene anologs and its preparing method and use UNIV SHENYANG PHARMACEUTICAL 2011-06-01 CN disclosed
CN-101070300-A Linonene anologs and its preparing method and use UNIV SHENYANG PHARMACY (CN) 2007-11-14 CN disclosed
EP-0509241-A2 A novel method for ether formation OCCIDENTAL CHEMICAL CORPORATION (US) 1992-10-21 EP disclosed
US-4352792-A 3-Alkoxyflavone antiviral agents HOFFMANN-LA ROCHE INC. (US) 1982-10-05 US disclosed